Lubell
Daniel Lubell, Northridge, CA US
Patent application number | Description | Published |
---|---|---|
20080267543 | Compliant Foil Fluid Film Radial Bearing Or Seal - A compliant foil fluid film bearing or seal apparatus includes a bushing having a plurality of peripherally separate bushing segments. The bushing has a bore defined therethrough, with a peripheral portion of the bore being defined on each bushing segment. A plurality of compliant foils is carried by the bushing, with at least one of the compliant foils being disposed on each bushing segment. A plurality of foil undersprings is disposed beneath the plurality of compliant foils. | 10-30-2008 |
Keith Lubell, New York, NY US
Patent application number | Description | Published |
---|---|---|
20120140024 | Method of displaying an enhanced three-dimensional images - The present invention relates to an image-capturing apparatus and methods, a recording medium, a program and a display device that allows for the displaying of enhanced integral images. In particular, the present invention relates to an information processing apparatus and methods, a recording medium, a program and a display device and a display method which provide images of an object having enhanced three-dimensional resolution while allowing various viewpoints of the images. | 06-07-2012 |
William Lubell, Montreal CA
Patent application number | Description | Published |
---|---|---|
20100210566 | AZAPEPTIDES AS CD36 BINDING COMPOUNDS - An azapeptide derivative of growth hormone releasing peptide (GHRP) of Formula I: A-(Xaa) | 08-19-2010 |
20120101257 | PROCESSES FOR PREPARING AMINO-SUBSTITUTED GAMMA-LACTAMS - The present application describes general process for the preparation of amino-substituted gamma-lactams involving the reaction of synthons of the general Formulae (I) and (VI): with amines. The processes are amenable to solid phase synthetic techniques and therefore allow the efficient incorporation of amino-substituted gamma-lactams into a wide variety of structural scaffolds, including, in particular peptides. | 04-26-2012 |
20120172318 | PEPTIDES AND PEPTIDOMIMETICS USEFUL FOR INHIBITING THE ACTIVITY OF PROSTAGLANDIN F2alpha RECEPTOR - The invention relates to compositions which are useful for inhibiting prostaglandin F | 07-05-2012 |
20130203686 | AZAPEPTIDES AS CD36 BINDING COMPOUNDS - An azapeptide compound of Formula I: | 08-08-2013 |
William A. Lubell, Montreal CA
Patent application number | Description | Published |
---|---|---|
20100038297 | Poly (Vinyl Alcohol) Polymers, Uses and Preparation Thereof - There are provided poly(vinyl alcohol) polymers and copolymers containing vinyl alcohol or vinyl acetate and derivatives thereof such as poly(ethylene glycol)-grafted poly(vinyl alcohol) polymers or polyether-grafted poly(vinyl alcohol) polymers. These polymers can contain various functional groups. Such polymers can be use as polymer matrix or solid support for various chemical substrates such as organic substrates and reagents. Cross-linked poly(vinyl alcohol) polymers and copolymers are also provided. Methods for preparing such polymers as well as several of their uses are also included. | 02-18-2010 |
William D. Lubell, Montreal CA
Patent application number | Description | Published |
---|---|---|
20100041609 | INTERLEUKIN-1 RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS OF TREATMENT - Peptides that are designed to inhibit the biological activity of the IL-1R type 1 receptor and inhibit IL-1R/IL-1RacP related cell signaling and biological activity are disclosed. Compositions comprising IL-1R antagonists of the present invention are useful in the treatment of IL-1 related diseases or conditions such as arthritis, rheumatoid arthritis, osteoarthritis, and inflammatory bowel disease as well as other chronic or acute inflammatory diseases. This invention also discloses an isolated compound having an IL-1R antagonist activity, said compound being selected from the group consisting of: a peptide comprising the amino acid sequence RYTPELX, wherein R, Y, T, P, E, L, refer to their corresponding amino acids, and X is selected from no amino acid and alanine (A); and a derivative of (a) wherein the derivative incorporates one, two or three amino acid modification selected from an amino acid addition, deletion or substitution in the RYTPEL portion of the peptide, and wherein said derivative maintains its antagonist IL-1R activity. | 02-18-2010 |
20100190710 | IL-23 RECEPTOR ANTAGONISTS AND USES THEREOF - The present invention relates to IL-23 receptor antagonists and agonists. The use of IL-23 receptor antagonists in treating autoimmune and inflammatory disorders, as well as methods of identifying IL-23 receptor antagonists and agonists. | 07-29-2010 |
20100204280 | CINNAMOYL INHIBITORS OF TRANSGLUTAMINASE - A compound of Formula, (I) or Formula: (II) | 08-12-2010 |
20120309690 | PROSTAGLANDIN-F2 ALPHA RECEPTOR MODULATORS AND USES THEREOF - Prostaglandin-F2 alpha (PGF2α) receptor (FP) modulators of formula I, as well as the use of PGF2α receptor modulators for the treatment of conditions associated with FP activity such as preterm labor and colorectal cancer, are disclosed. | 12-06-2012 |
20140024606 | PEPTIDOMIMETICS COMPRISING N-AMINO CYCLIC UREA RESIDUES AND USES THEREOF - Novel peptidomimetics comprising N-amino cyclic urea residues are disclosed. Use of such peptidomimetics for modulating the activity of CD36 or IL-1 receptor in a cell, and for treating CD36- or IL-1-related disease, disorder or condition is also described | 01-23-2014 |
20140024837 | CINNAMOYL INHIBITORS OF TRANSGLUTAMINASE - A compound of Formula I or Formula II: | 01-23-2014 |